DrugPatentWatch Database Preview
Drugs in Development Information for Carisbamate
» See Plans and Pricing
What is the development status for investigational drug Carisbamate?
Carisbamate is an investigational drug.
There have been 14 clinical trials for Carisbamate.
The most recent clinical trial was a Phase 3 trial, which was initiated on January 1st 2009.
The most common disease conditions in clinical trials are Epilepsy, Epilepsies, Partial, and Seizures. The leading clinical trial sponsors are SK Life Science, SK Life Science, Inc., and Baylor College of Medicine.
Summary for Carisbamate
| US Patents | 0 |
| International Patents | 0 |
| US Patent Applications | 135 |
| WIPO Patent Applications | 82 |
| Japanese Patent Applications | 21 |
| Clinical Trial Progress | Phase 3 (2009-01-01) |
| Vendors | 14 |
Recent Clinical Trials for Carisbamate
| Title | Sponsor | Phase |
|---|---|---|
| Bioavailability and Food Effect Study of 3 Types of Carisbamate | PRA Health Sciences | Phase 1 |
| Bioavailability and Food Effect Study of 3 Types of Carisbamate | SK Life Science, Inc. | Phase 1 |
| Carisbamate Safety Study in Adult and Pediatric Subjects With Lennox-Gastaut Syndrome | SK Life Science, Inc. | Phase 1 |
Clinical Trial Summary for Carisbamate
Top disease conditions for Carisbamate
Top clinical trial sponsors for Carisbamate
US Patents for Carisbamate
| Drugname | Patent Number | Patent Title | Patent Assignee | Estimated Expiration |
|---|---|---|---|---|
| >Drugname | >Patent Number | >Patent Title | >Patent Assignee | >Estimated Expiration |
